Table 3 Oligos and antibodies used in the research.
miR-155-5p-RT | GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACACCCCT | For miR-155-5p RT-qPCR |
miR-155-5p-F | GCGCTTAATGCTAATCGTGAT | |
miR-155-5p-R | CCAGTGCAGGGTCCGAGGTA | |
miR-574-5p-RT | GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACACACAC | For miR-574-5p RT-qPCR |
miR-574-5p-F | GGCTGAGTGTGTGTGTGTGA | |
miR-574-5p-R | CCAGTGCAGGGTCCGAGGTA | |
miR-187-3p-RT | GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCCGGCT | For miR-187-3p RT-qPCR |
miR-187-3p-F | GGCTCGTGTCTTGTGTTGC | |
miR-187-3p-R | CCAGTGCAGGGTCCGAGGTA | |
miR-130a-3p-T | GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACATGCCC | For miR-130a-3p RT-qPCR |
miR-130a-3p-F | GCGCCAGTGCAATGTTAAAA | |
miR-130a-3p-R | CCAGTGCAGGGTCCGAGGTA | |
miR-181b-5p-RT | GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACACCCAC | For miR-181b-5p RT-qPCR |
miR-181b-5p-F | GCAACATTCATTGCTGTCG | |
miR-181b-5p-R | CCAGTGCAGGGTCCGAGGTA | |
miR-361-5p-RT | GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACGTACCC | For miR-361-5p RT-qPCR |
miR-361-5p-F | GCGCTTATCAGAATCTCCAG | |
miR-361-5p-R | CCAGTGCAGGGTCCGAGGTA | |
miR-16-RT | GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCGCCAA | For miR-16 RT-qPCR |
miR-16-F | GCGCGCTAGCAGCACGTAAATA | |
miR-16-R | CCAGTGCAGGGTCCGAGGTA | |
GAPDH-F | GCACCGTCAAGGCTGAGAAC | For GAPDH RT-qPCR |
GAPDH-R | TGGTGAAGACGCCAGTGGA | |
U6-F | CTCGCTTCGGCAGCACA | For U6 RT-qPCR |
U6-R | AACGCTTCACGAATTTGCGT | |
ACOT12-F | TGCTGGAGTTTCCTGCGTTAC | For ACOT12 RT-qPCR |
ACOT12-R | GCATATCCTGTACCATGACCTTG | |
TWIST2-F | ACAGCAGTGACATCGGACAG | For TWIST2 RT-qPCR |
TWIST2-R | CCCCAAACATAAGACCCAGA | |
Vimentin-F | GAGAACTTTGCCGTTGAAGC | For Vimentin RT-qPCR |
Vimentin-R | GCTTCCTGTAGGTGGCAATC | |
N-cadherin-F | ACAGTGGCCACCTACAAAGG | For N-cadherin RT-qPCR |
N-cadherin-R | CCGAGATGGGGTTGATAATG |
